The oligonucleotide synthesis market is sized on the basis of a triangulation methodology that is primarily based on experimental modeling approaches such as patient-level data or disease epidemiology for any major indication, number of procedures, and obtaining accurate market estimates. To establish base analysis for any tool. Base year as well as in historical data analysis. The bottom-up approach is always used to obtain insightful data on oligonucleotide synthesis for specific country/regions. The country specific data is re-analyzed to get the data at the global level. The specific factors/parameters are considered to be related to the individual oligonucleotide synthesis market and quantified with practical reasoning.
Demand Analysis of the Oligonucleotide Synthesis Market provides a comprehensive analysis of the diverse characteristics, demand, product development, revenue generation and sales of the Oligonucleotide Synthesis Market across the globe.
Key Facts of the Global Oligonucleotide Synthesis Market Study
· By product, the synthesized oligonucleotides are anticipated to find substantial applications. The market potential is anticipated to increase with the therapeutic suitability for the treatment of neurodegenerative diseases and cancer. This segment is estimated to capture more than 3/5 of the total market share.
· Applications in medical science are projected to expand at a stellar rate of 18.4% through 2025. The market growth is anticipated to be driven by an increase in the availability of therapies such as antisense oligonucleotides and nucleic acid aptamers to treat dystrophy, cancer and other neurological conditions.
· The use of oligonucleotide synthesis in the research segment is set to register a significant growth rate over the forecast period. The increasing potential use of oligonucleotides in polymerase chain reaction (PCR) and next generation sequencing is anticipated to enhance the growth prospects of the major market players.
· Biotechnology and pharmaceutical companies emerge as major end users of oligonucleotide synthesis and are set to register a strong CAGR of 15.5% by 2025. Increased FDA approvals for oligonucleotides as therapeutic agents, strong R&D pipelines of pharmaceutical and biotechnology companies, and growth in clinical trials are important growth drivers for new diseases.
· Asia Pacific is an emerging hub for the global oligonucleotide synthesis market. This is due to an increase in life science research and development, government initiatives, grants and funding, and designation of research areas. The regional market is projected to expand at a CAGR of 12.5% during the forecast period.
· North America continues to maintain its lead in the global market, thanks to the rapid expansion of the life sciences industry, the presence of market players focusing on oligonucleotides as therapeutic agents such as antisense and RNAi therapeutics, and genetics in research diagnostics. and is driven by a strong focus on genomics.
